Table 2 Intravenous iron prescribing practices
Question (n = number of responses) | Frequency (n) | Percentage (%) |
|---|---|---|
Prescribe IV iron in pregnancy (n = 444) | ||
Yes | 426 | 95.9 |
No | 18 | 4.1 |
Prescribe IV iron postpartum (n = 429) | ||
Yes | 364 | 84.8 |
No | 65 | 15.2 |
Location of IV iron administration (n = 421) | ||
Hospital | 386 | 91.7 |
Non-hospital | 4 | 1.0 |
Both | 31 | 7.4 |
Number of infusions prescribed in pregnancy and/or postpartum per annum (n = 425) | ||
< 10 | 132 | 31.1 |
10–19 | 107 | 25.2 |
20–29 | 80 | 18.8 |
30 or more | 97 | 22.8 |
Don’t prescribe | 9 | 2.1 |
IV preparation prescribed (n = 425)a | ||
Ferric carboxymaltose (Ferinject) | 381 | 89.6 |
Iron polymaltose (Ferrosig, Ferrum-H) | 54 | 12.7 |
Don’t know | 16 | 3.8 |
Iron sucrose (Venofer) | 11 | 2.6 |
Othera | 7 | 1.6 |
Gestation range of IV iron prescribing in IDAP (n = 419)b | ||
Prescribe during pregnancy | 410 | 97.9 |
< 13 weeks | 35 | 8.4 |
13–27 weeks | 145 | 34.6 |
≥ 28 weeks | 406 | 96.9 |
Do not prescribe in pregnancy | 9 | 2.1 |
Gestation range of IV iron prescribing in pregnancy for ID without anaemia (n = 413)7 | ||
Prescribe during pregnancy | 220 | 53.3 |
< 13 weeks | 14 | 3.4 |
13–27 weeks | 51 | 12.3 |
≥ 28 weeks | 220 | 53.3 |
Do not prescribe | 193 | 46.7 |